299 related articles for article (PubMed ID: 29311917)
1. Human Adenosine A
Carpenter B; Lebon G
Front Pharmacol; 2017; 8():898. PubMed ID: 29311917
[TBL] [Abstract][Full Text] [Related]
2. Molecular Dynamics Simulations of Adenosine Receptors: Advances, Applications and Trends.
Al-Shar'i NA; Al-Balas QA
Curr Pharm Des; 2019; 25(7):783-816. PubMed ID: 30834825
[TBL] [Abstract][Full Text] [Related]
3. Adenosine receptors and Huntington's disease.
Lee CF; Chern Y
Int Rev Neurobiol; 2014; 119():195-232. PubMed ID: 25175968
[TBL] [Abstract][Full Text] [Related]
4. Structural Mapping of Adenosine Receptor Mutations: Ligand Binding and Signaling Mechanisms.
Jespers W; Schiedel AC; Heitman LH; Cooke RM; Kleene L; van Westen GJP; Gloriam DE; Müller CE; Sotelo E; Gutiérrez-de-Terán H
Trends Pharmacol Sci; 2018 Jan; 39(1):75-89. PubMed ID: 29203139
[TBL] [Abstract][Full Text] [Related]
5. Involvement of cAMP-PKA pathway in adenosine A1 and A2A receptor-mediated regulation of acetaldehyde-induced activation of HSCs.
Yang Y; Wang H; Lv X; Wang Q; Zhao H; Yang F; Yang Y; Li J
Biochimie; 2015 Aug; 115():59-70. PubMed ID: 25956975
[TBL] [Abstract][Full Text] [Related]
6. Studying the collective motions of the adenosine A2A receptor as a result of ligand binding using principal component analysis.
Martínez-Archundia M; Correa-Basurto J; Montaño S; Rosas-Trigueros JL
J Biomol Struct Dyn; 2019 Nov; 37(18):4685-4700. PubMed ID: 30661450
[TBL] [Abstract][Full Text] [Related]
7. Role of adenosine A2a receptor in cancers and autoimmune diseases.
Ye H; Zhao J; Xu X; Zhang D; Shen H; Wang S
Immun Inflamm Dis; 2023 Apr; 11(4):e826. PubMed ID: 37102661
[TBL] [Abstract][Full Text] [Related]
8. Structures of Human A
Cheng RKY; Segala E; Robertson N; Deflorian F; Doré AS; Errey JC; Fiez-Vandal C; Marshall FH; Cooke RM
Structure; 2017 Aug; 25(8):1275-1285.e4. PubMed ID: 28712806
[TBL] [Abstract][Full Text] [Related]
9. Substituted 4-phenylthiazoles: Development of potent and selective A
Abdelrahman A; Yerande SG; Namasivayam V; Klapschinski TA; Alnouri MW; El-Tayeb A; Müller CE
Eur J Med Chem; 2020 Jan; 186():111879. PubMed ID: 31780082
[TBL] [Abstract][Full Text] [Related]
10. Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives.
Deb PK; Deka S; Borah P; Abed SN; Klotz KN
Curr Pharm Des; 2019; 25(25):2697-2715. PubMed ID: 31333094
[TBL] [Abstract][Full Text] [Related]
11. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
Abbracchio MP; Cattabeni F
Ann N Y Acad Sci; 1999; 890():79-92. PubMed ID: 10668415
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives.
Al-Attraqchi OHA; Attimarad M; Venugopala KN; Nair A; Al-Attraqchi NHA
Curr Pharm Des; 2019; 25(25):2716-2740. PubMed ID: 31333093
[TBL] [Abstract][Full Text] [Related]
13. Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and Immunotherapy.
Franco R; Rivas-Santisteban R; Navarro G; Reyes-Resina I
Cells; 2021 Oct; 10(11):. PubMed ID: 34831054
[TBL] [Abstract][Full Text] [Related]
14. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
[TBL] [Abstract][Full Text] [Related]
15. Cross-communication between G
Navarro G; Cordomí A; Brugarolas M; Moreno E; Aguinaga D; Pérez-Benito L; Ferre S; Cortés A; Casadó V; Mallol J; Canela EI; Lluís C; Pardo L; McCormick PJ; Franco R
BMC Biol; 2018 Feb; 16(1):24. PubMed ID: 29486745
[TBL] [Abstract][Full Text] [Related]
16. Novel approaches for targeting the adenosine A2A receptor.
Yuan G; Gedeon NG; Jankins TC; Jones GB
Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639
[TBL] [Abstract][Full Text] [Related]
17. Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer.
Ferré S; Bonaventura J; Tomasi D; Navarro G; Moreno E; Cortés A; Lluís C; Casadó V; Volkow ND
Neuropharmacology; 2016 May; 104():154-60. PubMed ID: 26051403
[TBL] [Abstract][Full Text] [Related]
18. X-ray structure breakthroughs in the GPCR transmembrane region.
Topiol S; Sabio M
Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Potentials of A2B Adenosine Receptor Ligands: Current Status and Perspectives.
Chandrasekaran B; Samarneh S; Jaber AMY; Kassab G; Agrawal N
Curr Pharm Des; 2019; 25(25):2741-2771. PubMed ID: 31333084
[TBL] [Abstract][Full Text] [Related]
20. A
De Filippo E; Hinz S; Pellizzari V; Deganutti G; El-Tayeb A; Navarro G; Franco R; Moro S; Schiedel AC; Müller CE
Biochem Pharmacol; 2020 Feb; 172():113718. PubMed ID: 31751537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
